Funding for this research was provided by:
New York University Abu Dhabi (Research Grant)
Received: 13 August 2020
Accepted: 26 May 2021
First Online: 25 June 2021
: New York University and New York University Abu Dhabi hold a patent for the use of oligopyridylamides to inhibit mutant p53 amyloid formation, with S. Kumar, A.D.H., M.M. and S.H. listed as inventors (US10500197B2).